You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 5, 2024

Investigational Drug Information for Ibudilast


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Ibudilast?

Ibudilast is an investigational drug.

There have been 22 clinical trials for Ibudilast. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2020.

The most common disease conditions in clinical trials are Alcohol Drinking, Alcoholism, and Sclerosis. The leading clinical trial sponsors are MediciNova, University of California, Los Angeles, and National Institute on Drug Abuse (NIDA).

There are seven hundred and ninety-two US patents protecting this investigational drug and seven international patents.

Recent Clinical Trials for Ibudilast
TitleSponsorPhase
Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS StudyUniversity of PennsylvaniaEarly Phase 1
A Randomized, Double-blind Placebo-Controlled Study of Ibudilast for Treating Alcohol Use DisorderUniversity of PennsylvaniaPhase 2
Canadian Adaptive Platform Trial for Long COVIDUniversity Health Network, TorontoPhase 2/Phase 3

See all Ibudilast clinical trials

Clinical Trial Summary for Ibudilast

Top disease conditions for Ibudilast
Top clinical trial sponsors for Ibudilast

See all Ibudilast clinical trials

US Patents for Ibudilast

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ibudilast ⤷  Try a Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP) ⤷  Try a Trial
Ibudilast ⤷  Try a Trial Therapeutic approaches for treating Parkinson's disease Pharnext (Issy les Moulineaux, FR) ⤷  Try a Trial
Ibudilast ⤷  Try a Trial Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Selecta Biosciences, Inc. (Watertown, MA) ⤷  Try a Trial
Ibudilast ⤷  Try a Trial Method of purifying authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag The Catholic University of America (Washington, DC) ⤷  Try a Trial
Ibudilast ⤷  Try a Trial Ultra-pure agonists of guanylate cyclase C, method of making and using same SYNERGY PHARMACEUTICALS, INC. (New York, NY) ⤷  Try a Trial
Ibudilast ⤷  Try a Trial Melanocortin-1 receptor-specific cyclic hexapeptides Palatin Technologies, Inc. (Cranbury, NJ) ⤷  Try a Trial
Ibudilast ⤷  Try a Trial Pyrazolopyridines and pyrazolopyrimidines Pfizer Inc. (New York, NY) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ibudilast

Drugname Country Document Number Estimated Expiration Related US Patent
Ibudilast Canada CA2961033 2034-09-11 ⤷  Try a Trial
Ibudilast European Patent Office EP3192791 2034-09-11 ⤷  Try a Trial
Ibudilast Japan JPWO2016039408 2034-09-11 ⤷  Try a Trial
Ibudilast World Intellectual Property Organization (WIPO) WO2016039408 2034-09-11 ⤷  Try a Trial
Ibudilast Australia AU2012222348 2031-03-01 ⤷  Try a Trial
Ibudilast Australia AU2012222351 2031-03-01 ⤷  Try a Trial
Ibudilast Australia AU2013224959 2031-03-01 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.